FDA Insight: Advisory Committee on COVID-19 Vaccines

Dr. Peter Marks, FDA's Director of the Center for Biologics Evaluation and Research, returns for his third episode to provide an update on COVID-19 vaccines and to discuss the upcoming Vaccines and Related Biological Products Advisory Committee meeting.

Click here to listen.

Join Dr. Anand Shah, FDA’s Deputy Commissioner for Medical and Scientific Affairs, and other FDA leaders as they provide their insight into issues facing the agency – including the COVID-19 pandemic and other emerging topics.

FDA Insight: Advisory Committee on COVID-19 Vaccines

Posts by Tag